Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Enanta Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ENANTA PHARMACEUTICALS INC (ENTA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

15 Apr 2014 Thomson Reuters Stock Report 12 $25.00

ENTA - Enanta Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR Ranking Report

www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

12 Apr 2014 Alpha Street Research 9 $24.00

Validea Guru Analysis Report for ENTA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

11 Apr 2014 Validea 0 $12.00

Value Graph: ENANTA PHARMA -- ENTA

11 Apr 2014 Ford Investor Services, Inc. 1 $12.00

ENANTA PHARMA (ENTA) Zacks Company Snapshot

04 Apr 2014 Zacks Investment Research Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Enanta Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Apr 2014 Wright Reports 36 $75.00

ENANTA PHARMA (ENTA) Zacks Company Snapshot

20 Mar 2014 Zacks Investment Research Inc. 1 $12.00

ENANTA PHARMA (ENTA) Zacks Company Snapshot

14 Mar 2014 Zacks Investment Research Inc. 1 $12.00

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review Summary Enanta Pharmaceuticals, Inc. (Enanta) is a biotechnol...

07 Mar 2014 GlobalData 30 $125.00